Freeman Jonathan E
SEC CIK 1708133 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PHIO | Phio Pharmaceuticals Corp. | Dir | 32.7K | — | — | 5 | 2022-02-15 | 2026-02-05 |
Transactions 5
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-06 | 2026-02-05 | PHIO | Phio Pharmaceuticals Corp. | Freeman Jonathan E | Dir | A - Grant | $0.00 | +16.6K | 32.7K | +103% | $0 | |
| 2025-09-15 | 2025-09-11 | PHIO | Phio Pharmaceuticals Corp. | Freeman Jonathan E | Dir | A - Grant | $0.00 | +14.7K | 16.1K | +1,085% | $0 | |
| 2024-09-13 | 2024-09-11 | PHIO | Phio Pharmaceuticals Corp. | Freeman Jonathan E | Dir | A - Grant | $0.00 | +1,000 | 1,000 | New | $0 | |
| 2023-02-22 | 2023-02-17 | PHIO | Phio Pharmaceuticals Corp. | Freeman Jonathan E | Dir | A - Grant | $0.00 | +1,500 | 3,197 | +88% | $0 | |
| 2022-02-16 | 2022-02-15 | PHIO | Phio Pharmaceuticals Corp. | Freeman Jonathan E | Dir | A - Grant | $0.00 | +10.0K | 20.4K | +96% | $0 |